Sign in

NCT07577973Not yet recruiting

The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension

The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension: A Three-Arm Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 14 May 2026

Brief summary (registry, in English)

This randomized controlled trial examines the effects of nurse-led self-acupressure at HT7, LI4, PC6, and EX3 points on blood pressure, stress, and well-being in adults with primary hypertension. Participants are randomized to real acupressure, sham acupressure, or usual care groups for 2 weeks.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
72 (estimated)
First submitted
5 May 2026
Start date
1 Jun 2026
Primary completion date
30 Sept 2026
Lead sponsor
Abant Izzet Baysal University
NCT number
NCT07577973

What you commit to

  • Study type: Interventional
  • Planned participants: 72
  • From 1 Jun 2026 to the primary completion date, 30 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of anticoagulant therapy

Other illness

  • Secondary hypertension
  • Severe cardiovascular disease (heart failure, myocardial infarction within 6 months)
  • Stroke history within 6 months
  • Skin lesions or infection at acupressure sites (HT7, LI4, PC6, EX3)

Other

  • Pregnancy or lactation
  • Peripheral neuropathy affecting sensation
  • Participation in another clinical trial within 30 days

Who the study is looking for

  • Aged 18-65 years
  • Diagnosed with primary hypertension (Stage 1 or 2)
  • Systolic blood pressure 130-179 mmHg or diastolic 80-109 mmHg
  • Taking antihypertensive medication
  • Able to understand and communicate in Turkish
  • Willing to provide written informed consent

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
A Family Health Center in Duzce
Coordinator of this site? Confirm its status
DüzceTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.